Zobrazeno 1 - 10
of 215
pro vyhledávání: '"Brian M. Zeglis"'
Autor:
Mansi, Luigi1 (AUTHOR) mansi.luigi@libero.it
Publikováno v:
European Journal of Nuclear Medicine & Molecular Imaging. Mar2024, Vol. 51 Issue 4, p934-935. 2p.
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 5 (2022)
ABSTRACT VlsE (variable major protein-like sequence, expressed) is an outer surface protein of the Lyme disease pathogen (Borreliella species) responsible for its within-host antigenic variation and a key diagnostic biomarker of Lyme disease. However
Externí odkaz:
https://doaj.org/article/07a522b29b3e48bc95c8324d5aaf7428
Autor:
Outi Keinänen, Eric J. Dayts, Cindy Rodriguez, Samantha M. Sarrett, James M. Brennan, Mirkka Sarparanta, Brian M. Zeglis
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract The proliferation of plastics in the environment continues at an alarming rate. Plastic particles have been found to be persistent and ubiquitous pollutants in a variety of environments, including sea water, fresh water, soil, and air. In li
Externí odkaz:
https://doaj.org/article/1dc3c5928bad4f8db06b2d7fd448c29b
Autor:
Douglas S. MacPherson, Dobeen Hwang, Samantha M. Sarrett, Outi Keinänen, Cindy Rodriguez, Christoph Rader, Brian M. Zeglis
Publikováno v:
Mol Pharm
Site-specifically modified radioimmunoconjugates exhibit superior in vitro and in vivo behavior compared to analogues synthesized via traditional stochastic methods. However, the development of approaches to site-specific bioconjugation that combine
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Poly(ADP-ribose)polymerase-1 (PARP1) is a DNA repair enzyme highly expressed in the nuclei of mammalian cells, with a structure and function that have attracted interest since its discovery. PARP inhibitors, moreover, can be used to induce synthetic
Externí odkaz:
https://doaj.org/article/cc5af923006348f2a7dc040330feceab
Autor:
Outi Keinänen, Kimberly Fung, Jacob Pourat, Vilma Jallinoja, Delphine Vivier, NagaVara Kishore Pillarsetty, Anu J. Airaksinen, Jason S. Lewis, Brian M. Zeglis, Mirkka Sarparanta
Publikováno v:
EJNMMI Research, Vol 7, Iss 1, Pp 1-12 (2017)
Abstract Background Pretargeting-based approaches are being investigated for radioimmunoimaging and therapy applications to reduce the effective radiation burden to the patient. To date, only a few studies have used short-lived radioisotopes for pret
Externí odkaz:
https://doaj.org/article/0fcf170bc14143cab53aa92849dad3cf
Autor:
Outi Keinänen, Samantha M. Sarrett, Samantha Delaney, Cindy Rodriguez, Eric J. Dayts, Emily Capone, Frederic Sauniere, Rodolfo Ippoliti, Gianluca Sala, Stefano Iacobelli, Brian M. Zeglis
Publikováno v:
Molecular Pharmaceutics.
Autor:
Brian M, Zeglis, Jason S, Lewis
Publikováno v:
New England Journal of Medicine. 387:2291-2293
Autor:
Charles A. Maitz, Samantha Delaney, Brendon E. Cook, Afaf R. Genady, Rebecca Hoerres, Marina Kuchuk, Georgios Makris, John F. Valliant, Saman Sadeghi, Jason S. Lewis, Heather M. Hennkens, Jeffrey N. Bryan, Brian M. Zeglis
Publikováno v:
Mol Pharm
The last decade has played witness to the creation of a highly effective approach to in vivo pretargeting based on the inverse electron demand Diels-Alder (IEDDA) click ligation between tetrazine (Tz) and trans-cyclooctene (TCO). Despite the steady p
Publikováno v:
Nature Protocols.